VetDC receives FDA conditional approval of first new drug for treating lymphoma in dogs

VetDC receives FDA conditional approval of first new drug for treating lymphoma in dogs

FORT COLLINS -- VetDC, Inc ., a veterinary cancer therapeutics company, today announced the U.S. Food and Drug Administrations Center for Veterinary Medicine has granted conditional approval of ... Read More

Wednesday January 4, 2017 0 comments Tags: Fort Collins, VetDC, Steven J. Roy, Tanovea-CA1

VetDC acquires rights to agent that shows promise in fighting pet cancer

VetDC acquires rights to agent that shows promise in fighting pet cancer

FORT COLLINS - VetDC Inc. announced it has acquired from San Francisco-based Pathway Therapeutics Inc. all rights to Pathway's investigational class of anti-cancer molecules, including PWT33597... Read More

By: InnovatioNews Thursday August 15, 2013 0 comments Tags: Fort Collins, Pathway Therapeutics, pet cancer, Steven J. Roy, VDC-597, VetDC

VetDC's pitch impresses judges at 2012 Venture Showcase, wins $7,500 cash prize at BioWest

VetDC's pitch impresses judges at 2012 Venture Showcase, wins $7,500 cash prize at BioWest

DENVER - VetDC , a spin-out company from the Colorado State University Veterinary School, picked up the $7,500 pitch prize Tuesday at the 2012 Venture Showcase, part of the 2012 BioWest... Read More

By: Steve Wednesday September 12, 2012 0 comments Tags: Denver, Ginger Graham, KromaTid, Mike Huckman, Siva Therapeutics, Steven J. Roy, SuviCa, VetDC